Non-Performing Assets / Total Loans (Annual)

Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made

Eli Lilly and Company (LLY) Non-Performing Assets / Total Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$45.04B
Net Income	$10.59B
Cost of Goods Sold	$8.42B
Gross Profit	$36.62B
Operating Expenses	$32.14B
Operating Income	$12.90B
Non-Operating Income/Expense	$-218.60M
Pre-Tax Income	$12.68B
Normalized Pre-Tax Income	$12.68B
Income after Taxes	$10.59B
Income from Continuous Operations	$10.59B
Consolidated Net Income/Loss	$10.59B
Normalized Income after Taxes	$10.59B
EBIT	$12.90B
EBITDA	$14.67B
Weighted-Average Shares Outstanding (Basic)	900.61M
Weighted-Average Shares Outstanding (Diluted)	904.06M
Earnings per Share (EPS) (Basic)	$11.76
Earnings per Share (EPS) (Diluted)	$11.71
Balance Sheet Financials
Current Assets	$32.74B
Property, Plant, and Equipment	$17.10B
Long-Term Assets	$45.98B
Total Assets	$78.71B
Current Liabilities	$28.38B
Long-Term Debt	$28.53B
Long-Term Liabilities	$36.07B
Total Liabilities	$64.44B
Common Equity	$14.27B
Tangible Shareholders Equity	$2.33B
Shareholders Equity	$14.27B
Common Shares Outstanding	947.54M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$8.82B
Cash Flow from Investing Activities	$-9.30B
Cash Flow from Financial Activities	$1.23B
Beginning Cash	$2.82B
End Cash	$3.27B
Increase/Decrease in Cash	$449.80M
Stock-Based Compensation	$645.60M
Common Stock Dividends Paid	$-4.68B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.15
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.67
Debt to Equity Ratio	2.36
Gross Margin	81.31%
Operating Margin	28.64%
EBIT Margin	28.64%
EBITDA Margin	32.56%
Pre-Tax Profit Margin	28.15%
Profit Margin	23.51%
Free Cash Flow	$3.76B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.57
Inventory Turnover	1.11
Receiveable Turnover	3.39
Days Sales in Receivables	107.58
Return on Equity	74.20%
Return on Tangible Equity	453.53%
Return on Assets	13.45%
Return on Investments	24.74%
Book Value Per Share	$15.06
Free Cash Flow per Share	$4.16
Operating Cash Flow per Share	$9.75

Data from Zacks Investment Research, Inc.